Recently, the medical equipment company NVision Medical announced the accomplishment of its B round financing, which has raised 12 million USD,leading by Arboretum Ventures, and followed by Catalyst Health Ventures.

Under the present medical system, the influence of human genome is very limited, because of some basic challenges: the providers cannot receive the related resources in time,

Recently, NEEQ (National Equities Exchange and Quotations) notice shows that Hefei Sunshine Medical Technology Co., Ltd was approved to list on the new OTC market and public transfer.

AUG 18, NEEQ (National Equities Exchange and Quotations) notice shows that Fapon Biotech Inc. was approved to list on the new OTC market and public transfer.

According to information in the industry, recently, based-in Zhang Jiang gene detection company Singlera Genomics had received A round funding of 20 million dollars.

Recently, Sydney-based biological diagnostic technology company Atomo Diagnostics had completed a round of finance, of which the total number was 3.5 million dollars.

Recently, Beijing Jabrehoo medical technology co., LTD. had held a signing ceremony with the United States Illumina in Beijing. The partners had made the strategic cooperation on jointly developing and promoting the assisted reproduction diagnosis methods

Nanosphere announced today that it has completed a $10 million public offering. The Northbrook, Illinois-based molecular diagnostics firm priced the offering at $.47 per share. Each share was coupled with a fi..

Over the past seven years, Celgene has emerged as one of the most active and creative deal-makers in the biopharma industry. Using my descriptors, not their’s (in case they don’t like them), here are t..

The oncolytic immunotherapy of Amgen yields unusually brilliant results this year. After it was approved by FDA in October, Imlygic was approved again in Europe last week. Now it becomes the first oncolytic immunother..

In December 21, 2015, genomics service provider GENEWIZ announced that it has signed a definitive agreement to acquire the U.S. company Beckman's genome business, the business includes global genome business, heal..

Switzerland's CRISPR Therapeutics and Germany's Bayer today announced a yet unnamed joint venture to develop ways to deliver CRISPR/Cas9 genome editing in a clinical setting. The deal brings together Baye..

In December 19 2015, the thanks meeting for the being listed of Zhuhai Encode Medical Engineering Co., Ltd. (833787) is held in Zhuhai Resort Hotel. In the meeting, hundreds of people from the national association of ..

Dutch molecular diagnostics firm Agendia recently announced that it and several partners have received a four-year fund, $6.8 million grant from the European Commission to study targeted therapies for colorectal cance..

AstraZeneca announced today it will acquire a majority stake in Acerta for $4 billion. As a result, AstraZeneca gains access to Acerta’s irreversible oral Bruton's tyrosine kinase (Btk) inhibitor, acalabruti..

Researchers from NYU Langone Medical Center have made available to the public an Apple ResearchKit-based app to monitor concussion symptoms over the 6 weeks after an initial diagnosis. The app is freely available for ..

Medtronic recently announced that it has collaborated with Samsung and developed the implantable App for regulating the nerve. In June of this year, the two companies had together developed a portable smart devices fo..

Wanda Information recently announced that it is intended to trade 43.24million shares to its counterparty at 22.99 yuan per share to acquire 99.4% stake of Shanghai Jiada Information Technology Co., Ltd. . The predict..

Abstract Gene coexpression network analysis has been shown effective in identifying functional coexpressed gene modules associated with complex human diseases. However, existing techniques to construct coexpression ne..

Belgium Long known for home-grown pharma anchors like UCB and the Flanders Institute for Biotechnology (VIB), Belgium’s biopharma industry has been enhanced in recent years by younger biotechs, two of which we..